M-COPA is a golgi disruptor which inhibits cell surface expression of MET protein and the ADP-ribosylation factor 1 (Arf1) activation. M-COPA also inhibits angiogenesis through suppression of both VEGFR1 2 and nuclear factor-kappaB (NF-kappaB) signaling pathways.
1-Palmitoyl-2-stearoyl-rac-glycerol, a diacylglycerol, features palmitic acid at the sn-1 position and stearic acid at the sn-2 position. This compound plays a role in identifying the fatty acyl chain properties of diacylglycerols that activate the ADP-ribosylation factor 1 GTPase-activating protein (ARF1 GAP).